Operating Segments (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Summary of segmental information
Revenues	$ 924,552	$ 1,144,788
Loss from Operations	(8,473,792)	(2,300,063)
Amortization and Depreciation Expense	17,646	11,920
Other Income, Net	55,565	49,760
Share-Based Compensation	63,691	79,573
Identifiable Assets	9,847,674		$ 7,775,360
Public Health Solutions [Member]
Summary of segmental information
Revenues	908,807	680,353
Loss from Operations	(158,502)	(9,011)
Amortization and Depreciation Expense	7,303	4,402
Share-Based Compensation	9,465	5,196
Identifiable Assets	813,121		1,018,673
Specialized BioTherapeutics [Member]
Summary of segmental information
Revenues	15,745	464,435
Loss from Operations	(7,357,853)	(1,335,557)
Amortization and Depreciation Expense	3,070	4,677
Other Income, Net	33,618	5,007
Share-Based Compensation	25,289	20,908
Identifiable Assets	64,351		41,705
Corporate [Member]
Summary of segmental information
Loss from Operations	(957,437)	(955,495)
Amortization and Depreciation Expense	7,273	2,841
Other Income, Net	21,947	44,753
Share-Based Compensation	28,937	$ 53,469
Identifiable Assets	$ 8,970,202		$ 6,714,982